Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington ’s Disease: A Retrospective Database Analysis

ConclusionsResults from this real-world analysis indicate that patients treated with deutetrabenazine are more adherent to treatment and have lower discontinuation rates compared with patients in the tetrabenazine cohort. However, a potential limitation is overestimated adherence, as claims for prescription fills may not capture actual use. Additional research is warranted to explore the differences in adherence patterns between treatments, which may inform treatment decision-making.
Source: Neurology and Therapy - Category: Neurology Source Type: research